The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Richard K. Bogan, MD, FCCP, FAASM1,2; John Harsh, PhD3; Sally Ibrahim, MD4,5; John C. Carter, MD5,6; Anne Marie Morse, DO7; Bruce C. Corser, MD8; Thomas Stern, MD9; Emmanuel Mignot, MD, PhD10; Yves Dauvilliers, MD, PhD11; Jacqueline Brooks, MBBCh, MRCPsych12; Brian Abaluck, MD12; Gretchen S. Richards, MS12
1University of South Carolina School of Medicine, Columbia, SC, USA; 2Medical University of South Carolina, Charleston, SC, USA; 3University of Colorado, Boulder, CO, USA; 4University Hospitals Cleveland Medical Center, Cleveland, OH, USA; 5Case Western Reserve University School of Medicine, Cleveland, OH, USA; 6The MetroHealth System, Cleveland, OH, USA; 7Geisinger Commonwealth School of Medicine, Geisinger Medical Center, Janet Weis Children’s Hospital, Danville, PA, USA; 8Sleep Management Institute, Cincinnati, OH, USA; 9Advanced Respiratory and Sleep Medicine, PLLC, Huntersville, NC, USA; 10Stanford Center for Sleep Sciences and Medicine, Redwood City, CA, USA; 11National Reference Network for Narcolepsy, Sleep and Wake Disorders Center, Department of Neurology, Gui de Chauliac Hospital, Montpellier, France. University of Montpellier, INSERM Institute for Neurosciences Montpellier, Montpellier, France; 12Alkermes, Inc., Waltham, MA, USA*
